# Major Recall Alert: Olympus Biopsy Valve, VISERA™ Imaging System Recalled Due to Rubber Fragment Detachment Concern
Olympus has issued an important recall investigation for its **Biopsy Valve** and **VISERA™ Imaging System - Valve** due to a growing number of complaints related to rubber fragment detachment in the slit of **MAJ-210** and **MAJ-1218**. This potential defect raises critical concerns for healthcare professionals and patients alike. Olympus emphasizes the need to strictly adhere to the manufacturer's **Instructions for Use (IFU)** to prevent potential risks and has committed to releasing an updated customer notification by **mid-2026**.
If your organization uses these products, it’s crucial to stay informed about the potential risks and recommended corrective measures. Keep reading for everything you need to know about this recall, its importance, and steps to take moving forward.
## Why This Recall is Important
Recalls involving medical equipment like Olympus biopsy valves are significant because they affect patient safety and treatment outcomes. With complaints of **rubber fragment detachment**, there is a risk that small fragments could enter the patient’s body during medical procedures, leading to serious complications, such as:
- Injury or damage to internal tissues.
- Procedure interruptions or delays.
- Potential contamination during biopsy procedures.
Healthcare professionals rely heavily on the integrity of biopsy valves in diagnostics and imaging, especially for procedures conducted using the **VISERA™ Imaging System**. Any suspected malfunction of this equipment warrants immediate action to mitigate risks.
## Details of the Recall
Here are the key details regarding this recall investigation:
- **Product Involved**: Biopsy Valve, VISERA™ Imaging System - Valve.
- **Models Affected**: MAJ-210 and MAJ-1218.
- **Reason for Recall**: An observed increase in complaints about rubber fragment detachment in the slit of the affected models.
- **Safety Note**: Olympus is reinforcing the importance of strictly following the **Instructions for Use (IFU)** to ensure safe operation of the products.
- **Next Steps**: Olympus is conducting further investigations and will issue an updated customer notification by **mid-2026**.
For complete details, visit the official recall page here: [Canadian Recalls – VISERA™ Imaging System](https://recalls-rappels.canada.ca/en/alert-recall/viseratm-imaging-system).
## What You Should Do
If your organization uses the specified Olympus biopsy valves or VISERA™ Imaging System, here are the immediate steps to follow:
- **Review inventory**: Check for the affected models (MAJ-210 and MAJ-1218) in your supply.
- **Adhere to IFU guidelines**: Follow the **Instructions for Use** without deviation to minimize potential risks during procedures.
- **Monitor updates**: Stay informed about Olympus’ ongoing investigation and await the updated customer notification anticipated by mid-2026.
- **Contact Olympus**: Reach out to their customer support team for further clarification or to report any issues related to the affected biopsy valves.
## Stay Safe – Get Instant Recall Alerts
With recalls such as this one, staying informed is critical. Delayed responses can lead to unwanted complications, making it essential for healthcare providers and medical organizations to receive real-time alerts.
Take control of your safety and compliance by downloading **[Recall Alert App]**, the best way to ensure that you never miss critical updates on medical equipment recalls. Get instant alerts, stay ahead of safety risks, and protect the well-being of your patients and staff.
[Download the App Now!]
Stay proactive and prioritize safety by keeping up with all crucial recall developments. Bookmark our blog for continuous updates on recalls, safety notices, and preventive actions.
---
**Source**: [Canadian Recalls – VISERA™ Imaging System](https://recalls-rappels.canada.ca/en/alert-recall/viseratm-imaging-system)